Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Researchers recommend use of inhaled beta-agonists on an as-needed basis in mild asthma

Sep. 27, 1996

Orally bioavailable LTD4 antagonists from Menarini

Sep. 27, 1996

Quinoline LTD4/LTE4 inhibitors from Ciba-Geigy

Sep. 27, 1996

E. Merck reports PDE IV inhibitors

Sep. 27, 1996

New cough/cold remedy introduced in the U.S.

Sep. 27, 1996

New hay fever remedy available for the fall allergy season

Sep. 27, 1996

Sepracor updates progress on (R)-albuterol

Sep. 20, 1996

Customized asthma treatment introduced in the U.S.

Sep. 20, 1996

LTD4 antagonist selected for further evaluation by Menarini

Sep. 20, 1996

Schering AG investigates LTB4 inhibitors

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...